IBDEI20S ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33845,1,3,0)
 ;;=3^Diabetes Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,33845,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,33845,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,33846,0)
 ;;=E13.22^^154^1707^1
 ;;^UTILITY(U,$J,358.3,33846,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33846,1,3,0)
 ;;=3^DM w/ Diabetic CKD,Other
 ;;^UTILITY(U,$J,358.3,33846,1,4,0)
 ;;=4^E13.22
 ;;^UTILITY(U,$J,358.3,33846,2)
 ;;=^5002671
 ;;^UTILITY(U,$J,358.3,33847,0)
 ;;=E83.30^^154^1708^25
 ;;^UTILITY(U,$J,358.3,33847,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33847,1,3,0)
 ;;=3^Phosphorus Metabolism Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,33847,1,4,0)
 ;;=4^E83.30
 ;;^UTILITY(U,$J,358.3,33847,2)
 ;;=^5002997
 ;;^UTILITY(U,$J,358.3,33848,0)
 ;;=E83.31^^154^1708^9
 ;;^UTILITY(U,$J,358.3,33848,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33848,1,3,0)
 ;;=3^Familial Hypophosphatemia
 ;;^UTILITY(U,$J,358.3,33848,1,4,0)
 ;;=4^E83.31
 ;;^UTILITY(U,$J,358.3,33848,2)
 ;;=^5002998
 ;;^UTILITY(U,$J,358.3,33849,0)
 ;;=E83.51^^154^1708^18
 ;;^UTILITY(U,$J,358.3,33849,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33849,1,3,0)
 ;;=3^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,33849,1,4,0)
 ;;=4^E83.51
 ;;^UTILITY(U,$J,358.3,33849,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,33850,0)
 ;;=E83.52^^154^1708^12
 ;;^UTILITY(U,$J,358.3,33850,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33850,1,3,0)
 ;;=3^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,33850,1,4,0)
 ;;=4^E83.52
 ;;^UTILITY(U,$J,358.3,33850,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,33851,0)
 ;;=E87.0^^154^1708^15
 ;;^UTILITY(U,$J,358.3,33851,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33851,1,3,0)
 ;;=3^Hyperosmolality and Hypernatremia
 ;;^UTILITY(U,$J,358.3,33851,1,4,0)
 ;;=4^E87.0
 ;;^UTILITY(U,$J,358.3,33851,2)
 ;;=^5003018
 ;;^UTILITY(U,$J,358.3,33852,0)
 ;;=E87.1^^154^1708^17
 ;;^UTILITY(U,$J,358.3,33852,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33852,1,3,0)
 ;;=3^Hypo-osmolality and Hyponatremia
 ;;^UTILITY(U,$J,358.3,33852,1,4,0)
 ;;=4^E87.1
 ;;^UTILITY(U,$J,358.3,33852,2)
 ;;=^5003019
 ;;^UTILITY(U,$J,358.3,33853,0)
 ;;=E87.2^^154^1708^1
 ;;^UTILITY(U,$J,358.3,33853,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33853,1,3,0)
 ;;=3^Acidosis
 ;;^UTILITY(U,$J,358.3,33853,1,4,0)
 ;;=4^E87.2
 ;;^UTILITY(U,$J,358.3,33853,2)
 ;;=^5003020
 ;;^UTILITY(U,$J,358.3,33854,0)
 ;;=E87.3^^154^1708^3
 ;;^UTILITY(U,$J,358.3,33854,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33854,1,3,0)
 ;;=3^Alkalosis
 ;;^UTILITY(U,$J,358.3,33854,1,4,0)
 ;;=4^E87.3
 ;;^UTILITY(U,$J,358.3,33854,2)
 ;;=^5003021
 ;;^UTILITY(U,$J,358.3,33855,0)
 ;;=E87.4^^154^1708^23
 ;;^UTILITY(U,$J,358.3,33855,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33855,1,3,0)
 ;;=3^Mixed Acid-Base Balance Disorder
 ;;^UTILITY(U,$J,358.3,33855,1,4,0)
 ;;=4^E87.4
 ;;^UTILITY(U,$J,358.3,33855,2)
 ;;=^5003022
 ;;^UTILITY(U,$J,358.3,33856,0)
 ;;=E86.9^^154^1708^28
 ;;^UTILITY(U,$J,358.3,33856,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33856,1,3,0)
 ;;=3^Volume Depletion,Unspec
 ;;^UTILITY(U,$J,358.3,33856,1,4,0)
 ;;=4^E86.9
 ;;^UTILITY(U,$J,358.3,33856,2)
 ;;=^332840
 ;;^UTILITY(U,$J,358.3,33857,0)
 ;;=E86.0^^154^1708^6
 ;;^UTILITY(U,$J,358.3,33857,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33857,1,3,0)
 ;;=3^Dehydration
 ;;^UTILITY(U,$J,358.3,33857,1,4,0)
 ;;=4^E86.0
 ;;^UTILITY(U,$J,358.3,33857,2)
 ;;=^332743
 ;;^UTILITY(U,$J,358.3,33858,0)
 ;;=E86.1^^154^1708^21
 ;;^UTILITY(U,$J,358.3,33858,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33858,1,3,0)
 ;;=3^Hypovolemia
 ;;^UTILITY(U,$J,358.3,33858,1,4,0)
 ;;=4^E86.1
 ;;^UTILITY(U,$J,358.3,33858,2)
 ;;=^332744
